Pediatrix Medical (MD) Price to Sales (2009 - 2026)

Pediatrix Medical (MD) has reported Price to Sales for 18 consecutive years, with 4.22 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales rose 58.66% year-over-year to 4.22 in Q2 2026; TTM through Jun 2026 was 1.05, a 64.23% increase from a year earlier, with the FY2025 full-year figure at 0.93, up 65.7% from the prior year.
• Price to Sales was 4.22 for Q2 2026 at Pediatrix Medical, up from 3.69 in the prior quarter.
• Over five years, Price to Sales peaked at 4.25 in Q1 2022 and troughed at 1.28 in Q2 2024.
• A 5-year average of 2.7 and a median of 2.6 in 2023 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales sank 49.15% in 2022 and soared 107.06% in 2025, its largest moves.
• Over 5 years, Price to Sales stood at 2.4 in 2022, then plunged by 34.39% to 1.57 in 2023, then jumped by 42.48% to 2.24 in 2024, then soared by 60.29% to 3.59 in 2025, then climbed by 17.34% to 4.22 in 2026.
• The last three Price to Sales figures came in at 4.22 (Q2 2026), 3.69 (Q1 2026), and 3.59 (Q4 2025), per Business Quant data.